SHIELDED-CELL & IMMUNOTHERAPY PAIRS
Dead / Abandoned — Abandoned — failure to respond (as of 23 Oct 2023)
What this means for you
This application is over — abandoned 10 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79347676
- Mark type
- Stylized text
- Filed
- 04 Jul 2022
- Abandoned
- 10 Oct 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for gene and cell therapy
- Class 042 — Scientific and technological services: Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy
- Class 044 — Medical, beauty and agricultural services: Gene and cell therapy services; consultant services in the fields of gene therapy and cell therapy
Owner
Prosecution history
- 09 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 13 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 24 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 23 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 23 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 23 Oct 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 May 2023 — REFUSAL PROCESSED BY IB
- 06 Apr 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Apr 2023 — REFUSAL PROCESSED BY MPU
- 18 Feb 2023 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 17 Feb 2023 — NON-FINAL ACTION WRITTEN
- 10 Feb 2023 — ASSIGNED TO EXAMINER